Product Information
TEMOZOLOMIDE 180 MG CAPSULE is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $21.4132 per EA under NDC 75834014514. Its NADAC has been published 16 times since Nov 20, 2024.
Strength
180 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834014514
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213328On Market Since
12/7/2021
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 180 MG CAPSULE has been published 16 times since Nov 20, 2024, and over the history we have for it it has risen 25.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.4132 per EA |
|---|---|
| All-time high | $21.4132 (Mar 5, 2025) |
| All-time low | $17.0736 (Nov 20, 2024) |
| Median price | $19.2434 |
| Average price | $19.2886 |
| Largest weekly change | +12.7% (Dec 18, 2024) |
| Weeks tracked | 16 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 180 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 180 MG CAPSULE, manufactured by Nivagen Pharmaceuticals Inc., is $21.4132 per EA (NDC 75834014514), effective Mar 5, 2025.
How has the price of TEMOZOLOMIDE 180 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 180 MG CAPSULE has risen 25.4%. It has been tracked across 16 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 180 MG CAPSULE?
Since Nov 20, 2024, the NADAC for TEMOZOLOMIDE 180 MG CAPSULE has ranged from a low of $17.0736 (Nov 20, 2024) to a high of $21.4132 (Mar 5, 2025), with a median of $19.2434 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 180 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as TEMOZOLOMIDE 180 MG CAPSULE, but none are currently priced below it.
Who manufactures TEMOZOLOMIDE 180 MG CAPSULE?
TEMOZOLOMIDE 180 MG CAPSULE (NDC 75834014514) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification